Cannabis & Psychedelics Articles
Adopting Automated Cannabis and Hemp Extraction Solutions
Analytical Cannabis speaks to the extractors using automated solutions to boost their productivity.
The Top 10 Cannabis Stories of 2022
Analytical Cannabis rounds up the year’s top cannabis stories, with a particular focus on research and testing.
Wendi Young on Cannabinoid Testing in Extracts
Young told the recent Analytical Cannabis Expo Europe Online 2022 audience of the importance of stability testing and how to properly conduct shelf stability studies that are effective for a wide variety of cannabis products.
Is Ayahuasca Safe? We Ask a Researcher
Dr. Perkins spoke with Technology Networks – the sister publication of Analytical Cannabis – to provide context on the latest research study and the next steps for the research group.
International Regulatory Developments For Key Psychedelics
Stephen Wright breaks down the lengthy process of getting a psychedelic medicine approved in the US.
The Dark Side of Psychedelic Trials
Dr. Markus Roggen, president and chief science officer of Vancouver-based Delic Labs, delves into the less favorable side of psychedelic research.
The Evolution of the European Cannabis Lab
The analytical lab model needs an upgrade to serve the medical cannabis industry, writes QNTM founders Justin Ihnken and Connor Murphy and Agilent's Anthony Macherone.
A Q&A With Infinite Chemical Analysis Labs’ Erik Paulson
Analytical Cannabis caught up with Paulson to learn more about his lab's recent study of hemp-derived THC products.
Cannabis Holds Promise For Pain Management, Reducing The Need For Opioid Painkillers – A Neurology Expert Explains How
Writing in the Conversation, Benjamin Land, a research associate professor of pharmacology at the University of Washington, explains how cannabis could be used as an opioid substitute.
